Skip to main content
ANI Pharmaceuticals, Inc. (ANIP)
NASDAQ: ANIP · Real-Time Price · USD
74.81
+0.77 (1.04%)
At close: Mar 9, 2026, 4:00 PM EDT
75.00
+0.19 (0.25%)
After-hours: Mar 9, 2026, 5:26 PM EDT

ANI Pharmaceuticals Revenue

In the year 2025, ANI Pharmaceuticals had annual revenue of $883.37M with 43.78% growth. ANI Pharmaceuticals had revenue of $247.06M in the quarter ending December 31, 2025, with 29.64% growth.

Revenue (ttm)
$883.37M
Revenue Growth
+43.78%
P/S Ratio
1.77
Revenue / Employee
$910,687
Employees
970
Market Cap
1.56B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025883.37M268.99M43.78%
Dec 31, 2024614.38M127.56M26.20%
Dec 31, 2023486.82M170.43M53.87%
Dec 31, 2022316.39M100.25M46.38%
Dec 31, 2021216.14M7.66M3.67%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Bausch Health Companies 10.27B
Perrigo Company 4.25B
Phibro Animal Health 1.46B
Evotec SE 887.40M
BioCryst Pharmaceuticals 874.84M
Collegium Pharmaceutical 780.57M
Alvotech 573.35M
HUTCHMED (China) 548.51M
Revenue Rankings

ANIP News

More News